1 / 9

ISOPT V

ISOPT V. March 11-14, 2004 Monte Carlo. ISOPP new name: ISOPT. International Symposium of Ocular Pharmacology and Pharmaceutics (ISOPP) has been changed to: International Symposium of Ocular Pharmacology and Therapeutics (ISOPT)

jaden
Télécharger la présentation

ISOPT V

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ISOPT V March 11-14, 2004 Monte Carlo

  2. ISOPP new name: ISOPT • International Symposium of Ocular Pharmacology and Pharmaceutics (ISOPP) • has been changed to: • International Symposium of Ocular Pharmacology and Therapeutics (ISOPT) as to better express the strong clinical angle of the symposium

  3. ISOPT • Drug development • Implementation of novel drug products in common practice • The audience • Drug developers • Clinicians in practice

  4. ISOPT V History: • Geneva, 1995 287 participants • Munich, 1997 319 participants • Lisbon, 2000 510 participants • Seville, 2002 423 participants Next: • Monte Carlo, 2004

  5. ISOPT Themes • Clinical Studies • Endpoints • Ethical dilemmas • Academia-industry-regulatory bodies relationship • Developmental costs • Evidence based medicine

  6. Prevention of AMD • Photodynamic Therapy • New anti-angiogenic technologies • Diabetic retinopathy • CME: a therapeutic challenge • Vitreoproliferative retinopathy ISOPT sessions • Cornea and ocular surface diseases • Glaucoma • Retina • Inflammation & Infection • Drug delivery

  7. ISOPT V specials • Mini-Symposia • Angiogenesis • Antioxidants • Imaging tools • Neuroprotection • Courses • Evidence based medicine • Submitting projects to the industry

  8. Participants Expectations • Clinicians: • A comprehensive overview • Direct interaction with drug developers • Industry: • Presentation of achievements • Open discussions with regulatory agents, clinicians and academicians • Formation of a platform for public address on topics mutual to all industry

  9. See You in Monte Carlo Hotel de Paris March 11 – 14, 2004

More Related